The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 15, 2022

Filed:

Dec. 02, 2014
Applicant:

Fresenius Medical Care Deutschland Gmbh, Bad Homburg, DE;

Inventors:

Christoph Wiktor, Gelnhausen, DE;

Arne Peters, Bad Homburg, DE;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61M 1/34 (2006.01); A61M 1/16 (2006.01);
U.S. Cl.
CPC ...
A61M 1/3427 (2014.02); A61M 1/16 (2013.01); A61M 1/1601 (2014.02); A61M 1/165 (2014.02); A61M 1/1635 (2014.02); A61M 1/1672 (2014.02); A61M 1/342 (2013.01); A61M 1/3465 (2014.02); A61M 2205/50 (2013.01); A61M 2205/7554 (2013.01);
Abstract

A device for extracorporeal blood treatment and a method for operating an extracorporeal blood treatment device provide for an ultrafiltrate pump of an ultrafiltration apparatus to be operated in a first and second operating mode. The ultrafiltrate pump is operated in the first operating mode in such a way that the pressure on the blood-side of the semipermeable membrane is higher than the pressure on the dialysate-side of the semipermeable membrane of a dialyser, so that during the first operating mode a predetermined amount of fluid is removed from an extracorporeal blood circuit via the semipermeable membrane of the dialyser. In the second operating mode, the ultrafiltrate pump is operated in such a way that the pressure on the blood-side of the semipermeable membrane is, at successive intervals, alternately higher and lower than the pressure on the dialysate-side of the semipermeable membrane of the dialyser, so that fluid is continuously removed from and supplied to the extracorporeal blood circuit via the semipermeable membrane (push/pull mode). Additional components, in particular a separate push/pull pump, are not required for operation of the blood treatment device in push/pull mode. This results in both lower dimensions and lower weight. Operation in push/pull mode can increase the service life of the dialyser and the clearance of the dialysis treatment can also be increased for certain substances.


Find Patent Forward Citations

Loading…